Skip to main content
SpringerLink
Log in

The Biological Role of Hypothalamic Hypophysiotropic Neuropeptides

  • Chapter
Advances and Technical Standards in Neurosurgery

Part of the book series: Advances and Technical Standards in Neurosurgery ((NEUROSURGERY,volume 14))

Abstract

Four decades ago, Sir Geoffrey Harris postulated that the anterior pituitary is under hypothalamic neurohormonal control52 thus linking the brain with the endocrine system. This concept has led to a very fruitful search for the neurohormonal substances of the hypothalamus, which reach the anterior pituitary via the portal system, a vascular short cut between the neural tissue of the brain and the endocrine tissue of the pituitary113 (hypophysiotropic peptides), or which are directly secreted into the general circulation (posterior lobe peptides).

Dedicated to Prof. M. M. Forell for his seventieth birthday.

Supported by the Deutsche Forschungsgemeinschaft (We 439/5-1)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe H, Engler D, Molitch ME, Bollinger-Gruber J, Reichlin S (1985) Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116: 1383–1390

    Article  PubMed  CAS  Google Scholar 

  2. Arimura A, Culler MD (1985) Regulation of growth hormone secretion. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 221–259

    Google Scholar 

  3. Baird A, Wehrenberg WB, Bohlen P, Ling N (1985) Immunoreactive and biologically active growth hormone-releasing factor in the rat placenta. Endocrinology 117: 1508–1601

    Article  Google Scholar 

  4. Bauer W, Briger U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31: 1133–1144

    Article  PubMed  CAS  Google Scholar 

  5. Beck-Peccoz P, Amr, S, Menezes-Ferreira M, Faglia G, Weintraub BD (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. New Engl J Med 312: 1085–1090

    Article  PubMed  CAS  Google Scholar 

  6. Ben-Jonathan N (1985). Dopamine: A prolactin-inhibiting hormone. Endocr Rev. 6: 564–589

    Article  PubMed  CAS  Google Scholar 

  7. Berelowitz M, LeRoith D, von Schenk H, etal. (1982) Somatostatin like immunoreactivity and biological activity is present in Tetrahymena pyri- formis, a ciliated protozoan. Endocrinology 110: 1934–1944

    Google Scholar 

  8. Berg D, Rjosk HK, Jánicke F, von Werder K (1983) Behandlung der hyperprolaktinámischen Amenorrhoe durch pulsatile Gabe von Gonadotropin-Releasing Hormonen.Geburtshilfe Frauenheilkd 43: 686–688

    Article  PubMed  CAS  Google Scholar 

  9. Berger G, Trouillas J., Bloch B, Sassolas G, Berger F, Partensky C, Chayvialle J A, Brazeau P, Claustrat B, Lesbros F, Girod C (1984) Multihormonal carcinoid tumor of the pancreas secreting growth hormone-releasing factor as a cause of acromegaly. Cancer 54: 2097–2108

    Article  PubMed  CAS  Google Scholar 

  10. Bernutz C, Kewenig M, Horn K, Pickardt CR (1985) Detection of thyroid disorders by use of basal thyrotropin values determined with an optimized sandwich enzyme immunoassay. Clin Chem 31: 289–292

    PubMed  CAS  Google Scholar 

  11. Besser GM, McNeilly AS, Anderson DC, Marshall JC, Harsoulis P, Hall R, Ormston BJ, Alexander L, Collins WP (1972) Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J 3: 267–271

    Article  PubMed  CAS  Google Scholar 

  12. Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Benoit FR, Bloom F, Guillemin R (1983) Immunohistochemical detection of growth hormone-releasing factor in brain. Nature 301: 607

    Article  PubMed  CAS  Google Scholar 

  13. Borges JLC, Gelato MC, Rogol AD, Vance ML, MacLeod RM, Loriaux DL, Rivier J, Blizzard RM, Furlanetto R, Evans WS, Kaiser DL, Merriam GR -(1983) Effects of human pancreatic tumor growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 2: 119

    Article  PubMed  CAS  Google Scholar 

  14. Borowski GD, Garofano CD, Rose LI, Lewy RA (1984) Blood pressure response to thyrotropin-releasing hormone in euthyroid subjects. J Clin Endocrinol Metab 58: 197

    Article  PubMed  CAS  Google Scholar 

  15. Brazeau P, Vale W, Burgus R, Ling N, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of pituitary im- munoreactive growth hormone. Science 179: 77–79

    Article  PubMed  CAS  Google Scholar 

  16. Brownstein MJ, Palkovits M, Saavedra JM, Bassiri R, Utiger RD (1974) Thyrotropin-releasing hormone in specific nuclei of rat brain. Science 185: 267–269

    Article  PubMed  CAS  Google Scholar 

  17. Burger HG, Patel YC (1977) Thyrotropin releasing hormone - TSH. Clin Endocrinol Metab 6: 83–100

    Article  PubMed  CAS  Google Scholar 

  18. Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R (1972) Primary structure of the hypo-thalamic luteinizing hormone-releasing factor (LRF) of ovine origin. Proc Natl Acad Sci USA 69: 278–282

    Article  PubMed  CAS  Google Scholar 

  19. Burgus R, Dunn TF, Desiderio D, Ward DN, Vale W, Guillemin R (1970) Characterization of the hypothalamic hypophysiotropic TSH-releasing factor (TRF) of ovine origin. Nature 226: 321–325

    Article  PubMed  CAS  Google Scholar 

  20. Carey RM, Varma SK, Drake CR, Thorner MO, Kovacs K, Rivier J, Vale W (1984) Ectopic secretion of corticotropin-releasing factor as a cause of Cushing’s syndrome. N Engl J Med 311: 13 - 20

    Article  PubMed  CAS  Google Scholar 

  21. Charlton BG, Leake A, Ferrie IN, Linton EA, Lowry PJ (1986) Corticotropin-releasing factor in plasma of depressed patients and controls. Lancet 1: 161 - 162

    Article  PubMed  CAS  Google Scholar 

  22. Chapman AJ, Williams G, Hockley AD, London DR (1985) Pituitary apoplexy after combined test of anterior pituitary function. Br Med J 291: 26

    Article  CAS  Google Scholar 

  23. Ch’ng LJC, Sandler LM, Kraenzlin ME, Burrin M, Joplin GF, Bloom SR (1985) Long term treatment of acromegaly with a long acting analogue of somatostatin. Br Med J 290: 284–285

    Article  Google Scholar 

  24. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL (1984) The corticotropin-releasing factor stimulation test: An aid in the evaluation of patients with Cushing’s syndrome. N Engl J Med 310: 622–626

    Article  PubMed  CAS  Google Scholar 

  25. Colturi TJ, Unger RH, Feldman M (1984) Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. J Clin Invest 74: 417–423

    Article  PubMed  CAS  Google Scholar 

  26. Deuben RR, Meites J (1964) Stimulation of pituitary growth hormone release by a hypothalamic extract in vitro. Endocrinology 74: 408

    Article  PubMed  CAS  Google Scholar 

  27. Dolva LO, Riddervold F, Thorsen RK (1983) Side effects of thyrotropin releasing hormone. Br Med J 287: 532

    Article  CAS  Google Scholar 

  28. Duick DS, Wahner HW (1979). Thyroid axis in patients with Cushing’s syndrome. Arch Int Med 139: 767 - 772

    Article  CAS  Google Scholar 

  29. Engel WK, Siddique T, Nicoloff JT (1983) Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet 1: 73 - 75

    Article  Google Scholar 

  30. Evans LEJ, Hunter P, Hall R, Johnston M, Roy VM (1975) A double blind trial of intravenous thyrotropin-releasing hormone in the treatment of reactive depression. Br J Psychiatry 127: 227 - 230

    Article  PubMed  CAS  Google Scholar 

  31. Faden AI, Jacobs TP, Holaday JW (1981) Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats. N Engl J Med 305: 1063 - 1067

    Article  PubMed  CAS  Google Scholar 

  32. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P (1973) Plasma growth hormone response to thyrotropin-releasing hormone in acromegaly. J Clin Endocrinol Metab 36: 1259–1262

    Article  PubMed  CAS  Google Scholar 

  33. Faglia C, Bitensky L, Pinchera A, Ferrari C, Parrachi A, Beck-Peccoz P, Ambrosi B, Spada A (1979) Thyrotropin secretion in patients with central hypothyroidism: Evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 48: 989–998

    Article  PubMed  CAS  Google Scholar 

  34. Fahlbusch R, Pickardt CR (1975) The effect of intraventricular TRH in patients with diseases of the hypothalamic and pituitary region. Acta Endocrinol 193: 90

    Google Scholar 

  35. Ferin M, Van Vugt D, Wardlaw S (1984) The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Rec Prog Horm Res 40: 441

    PubMed  CAS  Google Scholar 

  36. Flückiger E, del Pozo E, von Werder K (1982). Prolactin, physiology, pharmacology and clinical findings. Monographs in Endocrinology 23, Springer, Berlin Heidelberg New York

    Google Scholar 

  37. Forest MG (1985) Sexual maturation of the hypothalamus: Pathophysiological aspects and clinical implications. Acta Neurochir (Wien) 75: 23–42

    CAS  Google Scholar 

  38. Franchimont P, Becker H, Ernould CH, Thys CH, Demoulin A, Bourguignon JP, Legros J J, Valcke JC (1974) The effect of hypothalamic luteinizing hormone releasing hormone (LHRH) on plasma gonadotropin levels in normal subjects. Clin Endocrinol 3: 27–29

    CAS  Google Scholar 

  39. Furutani Y, Morimoto Y, Shibahara S, etal (1983) Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor. Nature 301: 537–540

    Article  PubMed  CAS  Google Scholar 

  40. Gerich JE, Lorenzi M, Schneider V, Forsham PH (1974) Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man. J Clin Endocrinol Metab 39: 1057–1060

    Article  PubMed  CAS  Google Scholar 

  41. Gerich JE, Lorenzi M, Bier D, Schneider V, Tsalikia E, Karam J, Forsham PH (1975) Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med 292: 985–989

    Article  PubMed  CAS  Google Scholar 

  42. Giguère V, Labrie F, Coté J, Coy DH, Sueiras-Diaz J, Schally AV (1982) Stimulation of cyclic AMP accumulation and adrenocorticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. Proc Natl Acad Sci USA 79: 3466

    Article  PubMed  Google Scholar 

  43. Gillies GE, Linton E A, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355–357

    Article  PubMed  CAS  Google Scholar 

  44. Gold PW, Goodwin FK, Wher T, Rebar R (1978) Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: Relationship to spinal fluid amine metabolism. Am J Psychiatry 134: 1028–1031

    Google Scholar 

  45. Goodman RH, Jacobs JW, Dee PC, Habener JF (1982) Somatostatin-28 encoded in a cloned cDNA obtained from a rat medullary thyroid carcinoma. J Biol Chem 257: 1156–1159

    PubMed  CAS  Google Scholar 

  46. Griffiths EC, Bennett GW (1983) Thyrotropin releasing hormone. Raven Press, New York

    Google Scholar 

  47. Gubler U, Monahan JJ, Lomedico PT, Bhatt RS, Collier KJ, Hoffman BJ, Böhlen P, Esch F, Ling N, Zeytin F, Brazeau P, Poonian MS, Gage LP (1983) Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somtocrinin. Proc Natl Acad Sci USA 80: 4311

    Article  PubMed  CAS  Google Scholar 

  48. Guillemin R (1978) The brain as an endocrine organ. Neurosci Res Program Bull 16: [Suppl] 1–25

    PubMed  Google Scholar 

  49. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585–587

    Article  PubMed  CAS  Google Scholar 

  50. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Bloch B, Mougin C, Zeytin F, Baird A (1984) Somatocrinin, the growth hormone releasing factor. Recent Prog Horm Res 40: 233–286

    PubMed  CAS  Google Scholar 

  51. Habermann J, Leisner B, Witte A, Pickardt CR, Scriba PC (1982) Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation (Results based on a screening investigation). J Endocrinol Invest 5: 153–156

    PubMed  CAS  Google Scholar 

  52. Harris GW (1948) Neural control of the pituitary gland. Physiol Rev 28: 134–179

    Google Scholar 

  53. Hinkle PM, Woroch EL, Tashjian AH Jr (1974) Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. J Biol Chem 249: 3085–3090

    PubMed  CAS  Google Scholar 

  54. Hofmann AR, Crowley WF (1982) Induction of puberty in men by longterm pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 307: 1237–1241

    Article  Google Scholar 

  55. Holl R, Fehm HL, Hetzel WD, Heinze E, Voigt KH (1985) Globaler Hypophysenstimulationstest mit Releasing-Hormonen. Dtsch Med Wochenschr 110: 953–955

    Article  PubMed  CAS  Google Scholar 

  56. Horn K, Erhardt F, Fahlbusch R, Pickardt CR, von Werder K, Scriba PC (1976) Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumour. J Clin Endocrinol Metab 43: 137–143

    Article  PubMed  CAS  Google Scholar 

  57. Imaki I, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y, Jibiki K, Demura H, Tsushima T, Ling N (1985) The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60: 290–293

    Article  PubMed  CAS  Google Scholar 

  58. Jackson IMD (1982) Thyrotropin releasing hormone. N Engl J Med 306: 145–155

    Article  PubMed  CAS  Google Scholar 

  59. Jackson IMD (1980) Diagnostic tests for the evaluation of pituitary tumors. In: Post KD, Jackson IMD, Reichlin S (eds). The pituitary adenoma. Plenum Press, New York

    Google Scholar 

  60. Jackson IMD (1978) Phylogenetic distribution and function of the hypophysi- otropic hormones of the hypothalamus. Am Zoologist 18: 385–399

    Article  CAS  Google Scholar 

  61. Jackson IMD, Reichlin S (1974) Thyrotropin releasing hormone (TRH): Distribution in the brain, blood and urine of the rat. Life Sci 14: 2253–2266

    Article  Google Scholar 

  62. Jacobs LS, Snyder PJ, Utiger RD, Daughaday WH (1973) Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab 36: 1069–1073

    Article  PubMed  CAS  Google Scholar 

  63. Kastin AJ, Ehrensing RH, Schalch DS, Anderson MS (1972) Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet 2: 740–742

    Article  PubMed  CAS  Google Scholar 

  64. Knobil E (1980) The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36: 53–88

    PubMed  CAS  Google Scholar 

  65. Knobil E, Plant TM, Wildt L, Blecher PE, Marshall G (1980) Control of the rhesus monkey menstrual cycle: permissive role of the hypothalamic gonadotrophin-releasing hormone. Science 207: 1371

    PubMed  CAS  Google Scholar 

  66. Kourides IA, Ridgway EC, Weintraub BC, Bigos ST, Gershengorn MC, Maloof F (1977) Thyrotropin-induced hyperthyroidism: Use of alpha and beta subunit levels to identify patients with pituitary tumours. J Clin Endocrinol Metab 45: 534–543

    Article  PubMed  CAS  Google Scholar 

  67. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor AM, Unger RH (1979) Somatostatinoma syndrome. Biochemical, morphological and clinical features. N Engl J Med 301: 285–292

    Article  PubMed  CAS  Google Scholar 

  68. Krieger DT, Condon EM (1978) Cyproheptadine treatment of Nelson’s syndrome: restoration of plasma ACTH circadian periodicity and reversal of response of TRF. J Clin Endocrinol Metab 46: 349–352

    Article  PubMed  CAS  Google Scholar 

  69. Krieger DT (1983) Physiopathology of Cushing’s disease. Endocr Rev 4: 22

    Article  PubMed  CAS  Google Scholar 

  70. Krulich L, Dhariwal APS, McCann SM (1968) Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83: 783–790

    Article  PubMed  CAS  Google Scholar 

  71. Labrie F, Dupont A, Belanger A (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer. In: Labrie F, Proulx L (eds) Endocrinology. Excerpta Medica, Amsterdam New York Oxford, pp 450–453

    Google Scholar 

  72. Labrie F, Veilleux R, Lefevre G, Coy DH, Sueiras-Diaz J, Schally AV (1982) Corticotropin-releasing factor stimulates accumulation of adenosine 3′,5′- monophosphate in rat pituitary corticotrophs. Science 216: 1007

    Article  PubMed  CAS  Google Scholar 

  73. Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KJ, Del Pozo E (1985) Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 313: 1576–1580

    Article  PubMed  CAS  Google Scholar 

  74. Lamberts SWJ, Verleun T, Oosterom R, DeJong F, Hackens WHL (1984) Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 58: 298–303

    Article  PubMed  CAS  Google Scholar 

  75. Lance VA, Murphy WA, Sueiras-Diaz J, Coy EH (1984) Superactive analogs of growth hormone releasing factor (l-29)-amide. Biochem Biophys Res Commun 119: 265

    Article  PubMed  CAS  Google Scholar 

  76. Laron Z, Keret R, Bauman B, Pertzelan A, Ben-Zeev Z, Olsen DB, Comaru- Schally AM, Schally AV (1984) Differential diagnosis between hypothalamic and pituitary hGH deficiency with the aid of synthetic GH-RH 1–44. Clin Endocrinol 21: 9

    Article  CAS  Google Scholar 

  77. Leitner JW, Rifkin RM, Maman A, Sussman KE (1979) Somatostatin binding to pituitary plasma membranes. Biochem Biophys Res Commun 87: 919–927

    Article  PubMed  CAS  Google Scholar 

  78. Leyendecker G, Wildt L (1983) Induction of ovulation with chronic- intermittent (pulsatile) administration of GnRH in hypothalamic amenorrhea. J Reprod Fertil 69: 397

    Article  PubMed  CAS  Google Scholar 

  79. Leyendecker G, Wildt L, Hansmann M (1980) Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of portable pump (Zyklomat)—a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab 51: 1214–1216

    Article  PubMed  CAS  Google Scholar 

  80. Lightman S, Unwin RJ, Graham K, Dimaline R, Mc Garrick G (1984) Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinemia. Effects of pretreatment with bromocriptine and dexamethasone. Eur J Clin Invest 14: 444–448

    Article  PubMed  CAS  Google Scholar 

  81. Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D (1981) Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men. N Engl J Med 305: 663–667

    Article  PubMed  CAS  Google Scholar 

  82. Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Guillemin R (1984) Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci USA 81: 4302–4306

    Article  PubMed  CAS  Google Scholar 

  83. Ling N, Zeytin F, Bohlen P, Esch F, Brazeau P, Wehrenberg WB, Baird A, Guillemin R (1985) Growth hormone releasing factor. Ann Rev Biochem 54: 403–423

    Article  PubMed  CAS  Google Scholar 

  84. Liuzzi A, Chiodini PG, Botalla L, Silvestrini F, Muller EE (1974) Growth hormone (GH)-releasing activity of TRH and GH lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses. J Clin Endocrinol Metab 39: 871–874

    Article  PubMed  CAS  Google Scholar 

  85. Losa M, Bock L, Schopohl J, Stalla GK, Müller OA, von Werder K (1984) Growth hormone releasing factor infusion does not sustain elevated GH- levels in normal subjects. Acta Endocrinol 107: 462–470

    PubMed  CAS  Google Scholar 

  86. Losa M, Müller OA, Sobieszczyk, von Werder K (1985) Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects. Clin Endocrinol 23: 715–720

    Article  CAS  Google Scholar 

  87. Losa M, Schopohl J, Stalla GK, Müller OA, von Werder K (1985) Growth hormone releasing factor-test in acromegaly: Comparison with other dynamic tests. Clin Endocrinol 23: 99–109

    Article  CAS  Google Scholar 

  88. Losa M, Schopohl J, Müller OA, von Werder K (1984) Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF 1- 44, GRF 1-40, GRF 1-29) in normal subjects. Klin Wochenschr 62: 1140–1143

    Article  PubMed  CAS  Google Scholar 

  89. Losa M, Stalla GK, Müller OA, von Werder K (1983) Human pancreatic growth hormone releasing factor (hpGRF): Dose response of GRF- and GH- levels. Klin Wochenschr 61: 1249–1253

    Article  PubMed  CAS  Google Scholar 

  90. Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DV, Crigler JF, Crowley WF (1983) Long-term treatment of central precocious puberty with longacting analogue of luteiniz¬ing hormone-releasing hormone. N Engl J Med 109: 1286–1290

    Article  Google Scholar 

  91. Masuda A, Shibasaki T, Nakahara M, Imahi T, Kiyosawa Y, Jikibi K, Demura H, Shizume K, Ling N (1985) The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH-secretion in man. J Clin Endocrinol Metab 60: 523–526

    Article  PubMed  CAS  Google Scholar 

  92. Matsuo H, Baba Y, Nair RMG, Arimura A, Schally AV (1971) Structure of the porcine LH- and FSH-releasing hormone. I. Proposed amino acid sequence. Biochem Biophys Res Commun 43: 1374–1439

    Article  Google Scholar 

  93. McCann SM (1983) Progress in neuroendocrinology: LH releasing (LHRH), basic and clinical aspects. J Endocrinol Invest 6: 24–251

    Google Scholar 

  94. McCann SM, Krulich L, Negro-Vilar A, Ojeda SR, Vijayan E (1980) Regulation and function of panhibin (somatostatin). Adv Biochem Psycho- pharmacol 22: 131–143

    CAS  Google Scholar 

  95. McCann SM (1971) Mechanism of action of hypothalamic hypophyseal stimulating and inhibiting hormones. In: Ganong WF, Martini L (eds) Frontiers in neuroendocrinology. Oxford University Press, New York, p 209

    Google Scholar 

  96. Melmed S, Braunstein GD, Horvath E, Ezrin C, Kovacs K (1983) Pa-thophysiology of acromegaly. Endocr Rev 4: 271

    Article  PubMed  CAS  Google Scholar 

  97. Melmed S, Ezrin C, Kovacs K, Goodman RS, Frohman LA (1985) Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med 312: 9

    Article  PubMed  CAS  Google Scholar 

  98. Metcalf G, Dettmar PW (1981) Is thyrotropin-releasing hormone an endo-genous ergotropic substance in the brain? Lancet 1: 586–589

    Article  PubMed  CAS  Google Scholar 

  99. Morley JE (1981) Neuroendocrine control of thyrotropin secretion. Endocr Rev 2: 396

    Article  PubMed  CAS  Google Scholar 

  100. Morris DV, Adeniyi-Jones R, Wheeler M, Sonksen P, Jacobs HS (1984) The treatment of hypogonadotrophic hypogonadism in men by the pulsatile infusion of luteinizing hormone-releasing hormone. Clin Endocrinol 21: 189–200

    Article  CAS  Google Scholar 

  101. Moss RL, McCann SM (1973) Induction of mating behavior in rats by luteinizing hormone releasing factor. Science 181: 177

    Article  PubMed  CAS  Google Scholar 

  102. Müller OA, Dörr HG, Hagen B, Stalla GK, von Werder K (1982) Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo pituitary-adrenal axis. Klin Wochenschr 60: 1485–1491

    Article  PubMed  Google Scholar 

  103. Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K (1985) Corticotropin releasing factor (CRF): Diagnostic implications. Acta Neurochir (Wien) 75: 49–59

    Article  Google Scholar 

  104. Müller OA, Stalla GK, von Werder K (1983) Corticotropin releasing factor: A new tool for the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 57: 227–229

    Article  PubMed  Google Scholar 

  105. Nahagawa K, Akikawa K, Matsubara M, Kubo M (1985) Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly. J Clin Endocrinol Metab 60: 306–310

    Article  Google Scholar 

  106. Naor Z, Catt KJ (1980) Independent actions of gonadotropin releasing hormone upon cyclic GMP production and LH release. J Biochem 225: 342

    Google Scholar 

  107. Nikolics K, Mason AJ, Szönyi E, Ramachandran J, Seeburg PH (1985) A prolactin-inhibiting factor within the precursor for human gonadotropin- releasing hormone. Nature 316: 511

    Article  PubMed  CAS  Google Scholar 

  108. Nillius SJ, Bergquist C, Wide L (1978) Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue—a new approach to birth control? Contraception 17: 537–544

    Article  Google Scholar 

  109. Odell WD, Swerdloff RS (1978) Abnormalities of gonadal function in men. Clin Endocrinol 8: 149–180

    Article  CAS  Google Scholar 

  110. Orci L, Baetens D, Dubois MP, Rufener C (1975) Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res 7: 400–402

    Article  PubMed  CAS  Google Scholar 

  111. Orth DN (1984) The old and the new in Cushing’s syndrome. N Engl J Med 310: 649–651

    Article  PubMed  CAS  Google Scholar 

  112. Orth DN, Jackson RY, DeCherney GS, DeBold CR, Alexander AN, Island DP, Rivier J (1983) Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and Cortisol. J Clin Invest 71: 587–595

    Article  PubMed  CAS  Google Scholar 

  113. Page RB (1982) Pituitary blood flow. Am J Physiol 243 (Endocrinol Metab 6) E427–E442

    PubMed  CAS  Google Scholar 

  114. Pandol SJ, Seifert H, Thomas MW, Rivier J, Vale W (1984) Growth hormone releasing factor stimulates pancreatic enzym secretion. Science 225: 326–328

    Article  PubMed  CAS  Google Scholar 

  115. Patel YC, Rao K, Reichlin S (1977) Somatostatin in human cerebrospinal fluid. N Engl J Med 296: 529–533

    Article  PubMed  CAS  Google Scholar 

  116. Pelletier G (1980) Immunohistochemical localization of somatostatin. Prog Histochem Cytochem 12 (3): 1–41

    PubMed  CAS  Google Scholar 

  117. Penny ES, Penman E, Price J, Rees LH, Sopwith AM, Wass JAH, Lytras N, Besser GM (1984) Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Br Med J 289: 453

    Article  CAS  Google Scholar 

  118. Philips HS, Hostetter G, Kerdelhue B, Kozlowski GB (1980) Immunocyto- chemical localization of LHRH in central olfactory pathways of hamster. Brain Res 193: 574

    Article  Google Scholar 

  119. Pickardt CR, Scriba PC. TRH (1985) Pathophysiologic and clinical implications. Acta Neurochir (Wien) 75: 43–48

    Article  CAS  Google Scholar 

  120. Pieters GFFM, Hermus ARMM, Smais AGH, Bertelink AKM, Benraad THJ, Kloppenborg PWC (1983) Responsiveness of the hypophyseal- adrenocortical axis to corticotropin releasing factor in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab 57: 513–516

    Article  PubMed  CAS  Google Scholar 

  121. Plewe G, Beyer J, Krause U, Neufeld M, Del Pozo E (1984) Long acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 2: 782–784

    Article  PubMed  CAS  Google Scholar 

  122. Polak JM, Pearse AGE, Grimelius L, Bloom SR, Arimura A (1975) Growth- hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet 5: 1220–1222

    Article  Google Scholar 

  123. Proulx L, Giguere V, Coté J, Labrie F (1984) Multiple factors involved in the control of ACTH secretion. J Endocrinol Invest 7: 257–263

    PubMed  CAS  Google Scholar 

  124. Raptis S, Rosenthal J, Gerich JE (eds) (1974) Proceedings of the 2nd International Symposium on somatostatin. Attempto, Tübingen University Press, Tübingen, FRG

    Google Scholar 

  125. Reichlin S (1985) Neuroendocrinology, In: Williams textbook of endocrinology, 7th ed, Saunders WB, Philadelphia, pp 492–567

    Google Scholar 

  126. Reichlin S (1983) Somatostatin. N Engl J Med 309: 1495-1501, 1556–1563

    Article  PubMed  CAS  Google Scholar 

  127. Reichlin S (1960). Growth and the hypothalamus. Endocrinology 67: 760

    Article  CAS  Google Scholar 

  128. Reichlin S, Martin JB, Jackson IMD (1978). Regulation of thyroid- stimulating hormone (TSH) secretion. In: Jeffcoate SL, Hutchinson JSM (eds). The endocrine hypothalamus. Academic Press, New York

    Google Scholar 

  129. Reid IA, Rose JC (1977) An intrarenal effect of somatostatin on water excretion. Endocrinology 100: 782–785

    Article  PubMed  CAS  Google Scholar 

  130. Richter D, Ivell R (1985) Gene organization, biosynthesis, and chemistry of neurohypophyseal hormones. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 127–148

    Google Scholar 

  131. Rivier J, Rivier C, Vale W (1984) Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat. Science 224: 889–891

    Article  PubMed  CAS  Google Scholar 

  132. Rivier C, Vale W (1983) Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113: 939

    Article  PubMed  CAS  Google Scholar 

  133. Rjosk HK, von Werder K, Fahlbusch R (1976) Hyperprolaktinämische Amenorrhoe. Geburtshilfe Frauenheilkd 36: 575–587

    PubMed  CAS  Google Scholar 

  134. Robert JF, Quigley ME, Yen SSC (1981) Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab 52: 583 - 585

    Article  Google Scholar 

  135. Root AW, Snyder PJ, Rezvani I, DiGeorge AM, Utiger RD (1973) Inhibition of thyrotropin-releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab 36: 103–107

    Article  PubMed  CAS  Google Scholar 

  136. Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20: 373–377

    Article  PubMed  CAS  Google Scholar 

  137. Saito H, Saito S, Yamazaki R, Hoso E (1984) Clinical value of radioimmunoassay of plasma growth hormone-releasing factor. Lancet 2: 401

    Article  PubMed  CAS  Google Scholar 

  138. Samson WK, McCann SM, Chud L, Dudley CA, Moss RL (1980) Intra and extrahypothalamic luteinizing hormone releasing hormone distribution in the rat with special reference to mesencephalic sites which contain both LHRH and single neurons responsive to LHRH. Neuroendocrinology 31: 66

    Article  PubMed  CAS  Google Scholar 

  139. Sandow J (1983) Clinical applications of LHRH and its analogues. Clin Endocrinol 18: 571 - 592

    Article  CAS  Google Scholar 

  140. Scanlon MF, Weightman DR, Shale DJ, More B, Heath M, Snow MH, Lewis M, Hall R (1979) Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin Endocrinol 10: 7–15

    Article  CAS  Google Scholar 

  141. Scheithauer BW, Carpenter PC, Bloch B, Brazeau P (1984) Ectopic secretion of a growth hormone releasing factor. Am J Med 76: 605–616

    Article  PubMed  CAS  Google Scholar 

  142. Schopohl J, Losa M, König A, Müller OA, Stalla GK, von Werder K (1986) Combined pituitary function test with four hypohalamic releasing hormones. Klin Wochenschr 64: 314–318

    Article  PubMed  CAS  Google Scholar 

  143. Schürmeyer TH, Knuth UA, Freischem CW, Sandow J, Bint Akhtar F, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59: 19–24

    Article  PubMed  Google Scholar 

  144. Schulte EH, Loriaux DL (1983) Safety of corticotropin-releasing factor. Lancet 1: 1222

    Article  PubMed  CAS  Google Scholar 

  145. Schusdziarra V, Rouillar D, Unger RH (1979) Oral administration of somatostatin reduces postprandial plasma triglycerides, gastrin and gut glucagon-like immunoreactivity. Life Sci 24: 1595–1600

    Article  PubMed  CAS  Google Scholar 

  146. Schusdziarra V, Zyznar E, Rouiller D, etal (1980) Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207: 530–532

    Article  PubMed  CAS  Google Scholar 

  147. Selye H (1936) A syndrome produced by diverse noxious agents. Nature 138: 32

    Article  Google Scholar 

  148. Sharp PS, Foley K, Chadal P, Kohner EM (1984) The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects. Clin Endocrinol 20: 497 - 501

    Article  CAS  Google Scholar 

  149. Sheldon H (1985) Growth hormone and prolactin: Chemistry, gene organization, biosynthesis, and regulation of gene expression. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 57–82

    Google Scholar 

  150. Shen LP, Pictet RL, Rutter WJ (1982) Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sei USA 79: 4575–4579

    Article  CAS  Google Scholar 

  151. Shibahara S, Morimoto Y, Furutani Y, etal (1983) Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2: 775–779

    PubMed  CAS  Google Scholar 

  152. Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, Ling N, Shizume K (1985) Plasma GH responses to GRH and insulin induced hypoglycemia in man. J Clin Endocrinol Metab 60: 1265–1267

    Article  PubMed  CAS  Google Scholar 

  153. Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, Ling N, Shizume K (1985) Plasma GH responses to GRH and insulin induced hypoglycemia in man. J Clin Endocrinol Metab 60: 1265–1267

    Article  PubMed  CAS  Google Scholar 

  154. Shibasaki T, Kiyosawa Y, Masuda A, Nakahara M, Imaki T, Wakabayashi I, Demura H, Shizume K, Ling N (1984) Distribution of growth hormone releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab 59: 263–268

    Article  PubMed  CAS  Google Scholar 

  155. Shields D, Warren TG, Green RF, Roth SE, Brenner MJ (1981) The primary events in the biosynthesis and post-translational processing of different precursors to somatostatin. In: Rich DH, Cross E (eds). Peptides: Synthesis- structure-function: Proceedings of the seventh American Peptide Symposium. Pierce Chemical Company, Rockford, 111, pp 471–479

    Google Scholar 

  156. Siler-Khodr TM (1983) Hypothalamic-like peptides of the placenta. Seminars in Reprod Endocrin 1: 321–333

    Article  Google Scholar 

  157. Snyder PJ, Jacobs LS, Rabello MM, Sterling FH, Shore RN, Utiger RD, Daughaday WH (1974) Diagnostic value of thyrotropin-releasing hormone in pituitary and hypothalamic diseases: Assessment of thyrotropin and pro¬lactin secretion in 100 patients. Ann Intern Med 81: 751 - 757

    PubMed  CAS  Google Scholar 

  158. Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973) Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest 52: 2324–2329

    Article  PubMed  CAS  Google Scholar 

  159. Snyder G, Naor Z, Fawcett CP, McCann SM (1980) Gonadotropin release and cyclic nucleotides: evidence for LHRH-induced elevation of cyclic GMP levels in gonadotrophs. Endocrinology 107: 1627

    Article  PubMed  CAS  Google Scholar 

  160. Snyder PJ, Utiger RD (1972) Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 34: 380–385

    Article  PubMed  CAS  Google Scholar 

  161. Sopwith AM, Penny ES, Besser GM, Rees LH (1985) Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor. Clin Endocrinol 22: 337–340

    Article  CAS  Google Scholar 

  162. Stalla GK, Hartwimmer J, Kaliebe T, Müller OA (1985) Radioimmunoassay of human corticotropin releasing factor (hCRF). Acta Endocr (Kbh) Suppl. 108: 18–19

    Google Scholar 

  163. Stalla GK, Hartwimmer J, von Werder K, Müller OA (1984) Ovine (o) and human (h) corticotropin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol 106: 289–297

    PubMed  CAS  Google Scholar 

  164. Suda T, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K (1985) Immunoreactive corticotropin-releasing factor in human plasma. J Clin Invest 76: 2026–2029

    Article  PubMed  CAS  Google Scholar 

  165. Takahashi JS, Zatz M (1982) Regulation of circadian rhythmicity. Science 217: 1104–1111

    Article  PubMed  CAS  Google Scholar 

  166. Tanjasiri P, Kozbur X, Florsheim WH (1976) Somatostatin in the physiologic feedback control of thyrotropin secretion. Life Sci 19: 657–660

    Article  PubMed  CAS  Google Scholar 

  167. Thorner MO, Frohman LA, Leong DA, Thominet J, Downs T, Hellman P, Chitwood J, Vaughan JM, Vale W, Besser GM, Lytras N, Edwards CRV, Schaff M, Gelato M, Krieger DT, Marcovitz S, Ituarte E, Boyd AE, Malarkey WB, Blackard WG, Prioleau G, Melmed S, Charest NJ (1984) Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 59: 846–849

    Article  PubMed  CAS  Google Scholar 

  168. Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Yale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70: 965–977

    Article  PubMed  CAS  Google Scholar 

  169. Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM (1985) Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 312: 4–9

    Article  PubMed  CAS  Google Scholar 

  170. Thorner MO, Spiess J, Vance ML, Rogol AD, Kaiser DL, Webster JD, Rivier J, Borges JL, Bloom SR, Cronin MJ, Evans WS, Mac Leod RM, Vale W (1983) Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1: 24–28

    Article  PubMed  CAS  Google Scholar 

  171. Usadel KH, Leuschner U, Überla KK (1980) Treatment of acute pancreatitis with somatostatin: a multicenter double-blind trial. N Engl J Med 303: 999–1000

    Article  PubMed  CAS  Google Scholar 

  172. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J (1983) Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39: 245–270

    PubMed  CAS  Google Scholar 

  173. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and ß- endorphine. Science 213: 1394–1397

    Article  PubMed  CAS  Google Scholar 

  174. Vale W, Vaughan J, Yamamoto G, Spiess J, Rivier J (1983) Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothy-ronine and dexamethasone on GH-secretion in vitro. Endocrinology 112: 1553–1555

    Article  PubMed  CAS  Google Scholar 

  175. Van Cauter E, Refetoff S (1985) Evidence for two subtypes of Cushing’s disease based on the analysis of episodic Cortisol secretion. N Engl J Med 312: 1343–1349

    Article  PubMed  Google Scholar 

  176. Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO (1985) Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1- 40). J Clin Invest 75: 1584–1590

    Article  PubMed  CAS  Google Scholar 

  177. Van Loon GR, Brown GM (1975) Secondary drug failure occurring during chronic treatment with LHRH: appearance of an antibody. J Clin Endocrinol Metab 41: 640–643

    Article  PubMed  Google Scholar 

  178. Veldhuis JD, Rogol AD, Johanson ML, Dufau ML (1983) Endogenous

    Google Scholar 

  179. Webb CB, Vance ML, Thorner MO, Perisutti G, Thominet J, Rivier J, Vale W, Frohman LA (1985) Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J Clin Invest 74: 96–103

    Article  Google Scholar 

  180. Waxman J (1984) Analogues of gonadotropin releasing hormone. Br Med J 288: 426–237

    Article  CAS  Google Scholar 

  181. Webb CB, Vance ML, Thorner MO, Perisutti G, Thominet J, Rivier J, Vale W, Frohman LA (1985) Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J Clin Invest 74: 96–103

    Article  Google Scholar 

  182. Weiner RI, Elias KA, Monnet F (1985) The role of vascular changes in the etiology of prolactin secreting anterior pituitary tumors. In: Mac Leod RM, Thorner MO, Scapagnini U (eds). Prolactin. Basic and clinical correlates. Fidia Research Series, Liviana Press, Padova, pp 641–653

    Google Scholar 

  183. Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58: 905–976

    PubMed  CAS  Google Scholar 

  184. Weissei M, Stummvoll HK, Kolbe H, Höfer R (1979) Basal and TRH- stimulated thyroid and pituitary hormones in various degrees of renal insufficiency. Acta Endocrinol 909: 23–32

    Google Scholar 

  185. Wenzel KW (1981) Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717–732

    Article  PubMed  CAS  Google Scholar 

  186. Wenzel KW (1981) Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717–732

    Article  PubMed  CAS  Google Scholar 

  187. von Werder K (1985) Recent advances in the diagnosis and treatment of hyperprolactinemia. In: Imura H (ed) The pituitary gland. Raven Press, New York, pp 405–439

    Google Scholar 

  188. von Werder K, Fahlbusch R (1978) GnRH and TRH stimulated GH secretion in active and inactive acromegaly. In: Voelter W, Gupta D (eds) Hypo¬thalamic hormones. Verlag Chemie, New York Weinheim, pp 677–683

    Google Scholar 

  189. von Werder K, Losa M, Müller OA, Schweiberer L, Fahlbusch R, Del Pozo E (1984) Treatment of metastasising GRF-producing tumour with a long- acting somatostatin analogue. Lancet 2: 282–283

    Article  Google Scholar 

  190. von Werder K, Müller OA (1975) Medical therapy of hypothalamic diseases. Acta Neurochir (Wien) 75: 147–151

    Article  Google Scholar 

  191. von Werder K, Müller OA (1985) Corticotropin- and growth hormone releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases. Neurosurg Rev 8: 155–165

    Article  Google Scholar 

  192. von Werder K, Müller OA, Hard R, Losa M, Stalla GK (1984) Growth hormone releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients. J Endocrinol Invest 7: 185–191

    Google Scholar 

  193. de Wied D (1982) Neuropeptides and psychopathology. Eur J Clin Invest 12: 281 - 284

    Article  PubMed  Google Scholar 

  194. Williams I, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone releasing factor in obesity. N Engl J Med 311: 1403–1407

    Article  PubMed  CAS  Google Scholar 

  195. Zingg HH, Patel YC (1982) Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest 70: 1101–1109

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik Innenstadt, University of Munich, Munich, Federal Republic of Germany

    K. von Werder

Authors
  1. K. von Werder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. London, UK

    L. Symon

  2. Brussels, Belgium

    J. Brihaye

  3. Rome, Italy

    B. Guidetti

  4. Homburg/Saar, Germany

    F. Loew

  5. Edinburgh, UK

    J. D. Miller

  6. Oslo, Norway

    H. Nornes

  7. Budapest, Hungary

    E. Pásztor

  8. Paris, France

    B. Pertuiset

  9. Zurich, Switzerland

    M. G. YaÅŸargil

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag/Wien

About this chapter

Cite this chapter

von Werder, K. (1986). The Biological Role of Hypothalamic Hypophysiotropic Neuropeptides. In: Symon, L., et al. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery, vol 14. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6995-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6995-7_3

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7466-1

  • Online ISBN: 978-3-7091-6995-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation